Part VIII U.K. Miscellaneous and Supplementary Provisions

Modifications etc. (not altering text)

110 Enforcement in Northern Ireland. U.K.

(1)Subject to the provisions of [F1subsections (3C) and (4)] of this section, it shall be the duty of the [F2Minister for Health, Social Services and Public Safety] (in this section referred to as “the Minister”) to enforce in Northern Ireland, or to secure the enforcement in Northern Ireland of, the provisions of this Act and of any regulations and orders made under it.

(2)For the purpose of performing that duty in relation to the provisions specified in [F3paragraph (a)] of subsection (2) of section 108 of this Act in their application as mentioned in [F4that paragraph], within the [F5district] of any [F6district council], the Minister may make arrangements or give directions whereby the [F6district council], to such extent as the arrangements or directions may provide, shall have power concurrently with the Minister, or shall be under a duty concurrently with him, to enforce the provisions specified in the said [F3paragraph (a)] in their application as so mentioned F7....

F8(3). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F9[F10(3A). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(3B)The Pharmaceutical Society [F11of Northern Ireland] shall be under a duty to enforce [F12the provisions of sections 72A and 72AA of this Act, and any regulations made under section 72A,] in their application to Northern Ireland.

(3C)The Minister shall be under no duty to enforce [F13those provisions, or any regulations made under section 72A,] in their application to Northern Ireland.

(3D)Notwithstanding subsection (3C) of this section the Minister is to be treated for the purposes of sections 111 to 114 of this Act—

(a)as empowered by this section to enforce [F14those provisions, or any regulations made under section 72A,] in their application to Northern Ireland, and

(b)to that extent as an enforcement authority in relation to those F15... provisions or those regulations in their application to Northern Ireland.]

F16(4). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(5)[F17Subsection (9)] of section 108 of this Act shall have effect in relation to Northern Ireland as if—

(a)in the said subsection (9) the reference to subsections [F18(2) to (6D)] of that section were a reference to subsections (2) [F19to (3D)] of this section; F20...

F20(b). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F21(6), (7) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

[F22(8)In this section “district council” means a council established under the Local Government Act (Northern Ireland) 1972.]

Textual Amendments

F1 Words in s. 110(1) substituted (1.10.2009) by Health Act 2006 (c. 28), ss. 31(3)(a), 83(7); S.I. 2008/2714, art. 2(a)

F2 Words in s. 110(1) substituted (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 34 para. 20(a) (with Sch. 32)

F5Word in s. 110(2) substituted (14.8.2012) by virtue ofThe Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 34 para. 20(b)(iii) (with Sch. 32)

F6Words in s. 110(2) substituted (14.8.2012) by virtue of The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 34 para. 20(b)(iv) (with Sch. 32)

F7 Words in s. 110(2) omitted (14.8.2012) by virtue of The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 34 para. 20(b)(v) (with Sch. 32)

F10 S. 110(3A)-(3D) inserted (1.10.2009) by Health Act 2006 (c. 28), ss. 31(3)(b), 83(7); S.I. 2008/2714, art. 2(a)

F11 Words in s. 110(3A)(3B) inserted (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 34 para. 20(d) (with Sch. 32)

F19 Words in s. 110(5)(a) substituted (1.10.2009) by Health Act 2006 (c. 28), ss. 31(3)(c) , 83(7); S.I. 2008/2714, art. 2(a)

F20 S. 110(5)(b) and word omitted (14.8.2012) by virtue of The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 34 para. 20(e)(iii) (with Sch. 32)

Modifications etc. (not altering text)

C2 Pt. VIII (ss. 104–136) extended by S.I.s 1982/425, art. 3, 1984/187 art. 2; and extended with modifications by S.I. 1985/403, art. 3(1)

C3 S. 110 modified (30.1.1992) by S.I. 1992/32, reg. 12(1)(2)

S. 110 extended (with modifications) (14.2.1994) by S.I. 1994/105, reg. 19, Sch.4

S. 110 applied (1.1.1995) by S.I. 1994/3142, reg. 18(2)

S. 110 applied (31.3.1997) by S.I. 1997/322, reg. 34, Sch.5

S. 110 extended (1.1.1995) by S.I.1994/ 3142, reg. 18(7)

S. 110 (except (4)) applied (with modifications) (1.1.1995) by S.I. 1994/3144 , reg.10

Ss. 108-110 applied (1.2.2000) by S.I. 2000/7, reg. 5

C4 Ss. 108-114 applied (with modifications) (1.7.1992) by S.I. 1992/1520, reg.12.

C5 Ss. 108-115 modified (3.4.1992) by S.I. 1992/605, regs. 2(3), 3

Ss. 108-115 applied (3.10.1994) by S.I. 1994/2328, reg. 11(c)

C6Ss. 107-116 applied (with modifications) (1.5.2004) by Medicines for Human Use (Clinical Trials) Regulations 2004 (S.I. 2004/1031), regs. 1, 47, Schs. 9

C8Ss. 107-116 amendment to earlier affecting provision SI 2004/1031 reg. 47 Sch. 9 (29.8.2006) by Medicines for Human Use (Clinical Trials) Amendment Regulations 2006 (S.I. 2006/1928), regs. 1(1), 32